Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

A rare skin reaction occurred when a man took paracetamol, causing a new rash in an area already affected by hair loss.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Both concentrations of triamcinolone acetonide are equally effective and safe for treating patchy alopecia areata.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Using Excimer light with topical steroids is the most effective treatment for alopecia areata.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

A rare genetic condition can mimic symptoms of other diseases, making diagnosis challenging.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Tislelizumab can cause cutaneous lupus erythematosus.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

JAK inhibitors show promise in treating difficult skin diseases.

Baricitinib is effective and safe for treating severe alopecia areata.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.